{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:51:59Z","timestamp":1757620319659,"version":"3.44.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial Medical Science and Technology Project","award":["LHGJ20240030","SBGJ202102015","SBGJ202102015","SBGJ202102015","LHGJ20240030","LHGJ20240030","LHGJ20240030"],"award-info":[{"award-number":["LHGJ20240030","SBGJ202102015","SBGJ202102015","SBGJ202102015","LHGJ20240030","LHGJ20240030","LHGJ20240030"]}]},{"name":"Henan Key Laboratory of Molecular Nuclear Medicine and Translational Medicine","award":["2020-27-4","2020-27-4","2020-27-4","2020-27-4","2020-27-4","2020-27-4"],"award-info":[{"award-number":["2020-27-4","2020-27-4","2020-27-4","2020-27-4","2020-27-4","2020-27-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12794-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:58:57Z","timestamp":1753732737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the diagnostic accuracy of 99mTc-labeled somatostatin receptor imaging for suspected pheochromocytomas and paragangliomas"],"prefix":"10.1038","volume":"15","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"12794_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders, J. W. M. et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metabolism. 99, 1915\u20131942 (2014).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"12794_CR2","doi-asserted-by":"crossref","unstructured":"Lenders, J. W. M. et al.\u00a0Biochemical Diagnosis of Pheochromocytoma.\u00a0JAMA.\u00a0 287, (2002).","DOI":"10.1001\/jama.287.11.1427"},{"key":"12794_CR3","doi-asserted-by":"crossref","unstructured":"Constantinescu, G. et al. Silent pheochromocytoma and paraganglioma: systematic review and proposed definitions for standardized terminology. Frontiers Endocrinology 13, (2022).","DOI":"10.3389\/fendo.2022.1021420"},{"key":"12794_CR4","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00259-024-06622-z","volume":"51","author":"Q He","year":"2024","unstructured":"He, Q. et al. Head-to-head comparison between [68Ga]Ga-DOTA-NOC and [18F]DOPA PET\/CT in a diverse cohort of patients with pheochromocytomas and paragangliomas. Eur. J. Nucl. Med. Mol. Imaging. 51, 1989\u20132001 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/RLU.0000000000004963","volume":"49","author":"C Sung","year":"2023","unstructured":"Sung, C. et al. A prospective comparative study of 18F-FDOPA PET\/CT versus 123I-MIBG scintigraphy with SPECT\/CT for the diagnosis of pheochromocytoma and paraganglioma. Clin. Nucl. Med. 49, 27\u201336 (2023).","journal-title":"Clin. Nucl. Med."},{"key":"12794_CR6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s00259-010-1545-7","volume":"37","author":"E Bombardieri","year":"2010","unstructured":"Bombardieri, E. et al. 131I\/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur. J. Nucl. Med. Mol. Imaging. 37, 2436\u20132446 (2010).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF00173284","volume":"19","author":"L Feggi","year":"1992","unstructured":"Feggi, L. et al. Pitfalls in scintigraphic detection of neuroendocrine tumours. Eur. J. Nucl. Med. 19, 214\u2013218 (1992).","journal-title":"Eur. J. Nucl. Med."},{"key":"12794_CR8","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Ta\u00efeb","year":"2019","unstructured":"Ta\u00efeb, D. et al. European association of nuclear medicine practice guideline\/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of Phaeochromocytoma and paraganglioma. Eur. J. Nucl. Med. Mol. Imaging. 46, 2112\u20132137 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00330-011-2289-x","volume":"22","author":"N Naswa","year":"2012","unstructured":"Naswa, N. et al. Prospective evaluation of 68Ga-DOTA-NOC PET-CT in Phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Eur. Radiol. 22, 710\u2013719 (2012).","journal-title":"Eur. Radiol."},{"key":"12794_CR10","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00259-012-2119-7","volume":"39","author":"JB Maurice","year":"2012","unstructured":"Maurice, J. B. et al. A comparison of the performance of 68Ga-DOTATATE PET\/CT and 123I-MIBG SPECT in the diagnosis and follow-up of Phaeochromocytoma and paraganglioma. Eur. J. Nucl. Med. Mol. Imaging. 39, 1266\u20131270 (2012).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.2967\/jnumed.116.187690","volume":"58","author":"I Janssen","year":"2017","unstructured":"Janssen, I. et al. Functional imaging signature of patients presenting with polycythemia\/paraganglioma syndromes. J. Nucl. Med. 58, 1236\u20131242 (2017).","journal-title":"J. Nucl. Med."},{"key":"12794_CR12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1210\/jc.2017-02324","volume":"103","author":"D Ta\u00efeb","year":"2018","unstructured":"Ta\u00efeb, D. et al. 18F-FDOPA PET\/CT imaging of MAX-related pheochromocytoma. J. Clin. Endocrinol. Metab. 103, 1574\u20131582 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12794_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2214\/AJR.21.26071","volume":"218","author":"A Jha","year":"2021","unstructured":"Jha, A. et al. Sporadic primary pheochromocytoma: A prospective intraindividual comparison of six imaging tests (CT, MRI, and PET\/CT using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA). AJR Am. J. Roentgenol. 218, 342\u2013350 (2021).","journal-title":"AJR Am. J. Roentgenol."},{"key":"12794_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","volume":"43","author":"A Archier","year":"2015","unstructured":"Archier, A. et al. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur. J. Nucl. Med. Mol. Imaging. 43, 1248\u20131257 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/wjnm.WJNM_41_17","volume":"17","author":"K Liepe","year":"2018","unstructured":"Liepe, K. & Becker, A. 99mTc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors. World J. Nucl. Med. 17, 151\u2013156 (2018).","journal-title":"World J. Nucl. Med."},{"key":"12794_CR16","doi-asserted-by":"publisher","first-page":"1326858","DOI":"10.3389\/fendo.2024.1326858","volume":"15","author":"B Li","year":"2024","unstructured":"Li, B. et al. [99mTc]Tc-HYNIC-ALUG SPECT\/CT in the initial staging of 227 consecutive patients with newly diagnosed prostate cancer: a 5-year monocentric retrospective study. Front. Endocrinol. 15, 1326858 (2024).","journal-title":"Front. Endocrinol."},{"key":"12794_CR17","doi-asserted-by":"publisher","first-page":"1228575","DOI":"10.3389\/fonc.2023.1228575","volume":"13","author":"B Li","year":"2023","unstructured":"Li, B. et al. Diagnostic accuracy of 99mTc-HYNIC-TOC SPECT\/CT for detecting osteomalacia-associated tumors. Front. Oncol. 13, 1228575 (2023).","journal-title":"Front. Oncol."},{"key":"12794_CR18","first-page":"708","volume":"44","author":"M Gabriel","year":"2003","unstructured":"Gabriel, M. et al. An intrapatient comparison of 99mTc-EDDA\/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. J. Nucl. Med. 44, 708\u2013716 (2003).","journal-title":"J. Nucl. Med."},{"key":"12794_CR19","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","volume":"49","author":"I Ilias","year":"2008","unstructured":"Ilias, I. et al. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J. Nucl. Med. 49, 1613\u20131619 (2008).","journal-title":"J. Nucl. Med."},{"key":"12794_CR20","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1210\/jc.2011-0333","volume":"96","author":"KS King","year":"2011","unstructured":"King, K. S. et al. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J. Clin. Endocrinol. Metab. 96, 2779\u20132785 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12794_CR21","first-page":"1114","volume":"41","author":"C Decristoforo","year":"2000","unstructured":"Decristoforo, C., Melendez-Alafort, L., Sosabowski, J. K. & Mather, S. J. 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. J. Nucl. Med. 41, 1114\u20131119 (2000).","journal-title":"J. Nucl. Med."},{"key":"12794_CR22","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1055\/s-2005-921092","volume":"37","author":"B Ueberberg","year":"2005","unstructured":"Ueberberg, B. et al. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm. Metab. Res. 37, 722\u2013728 (2005).","journal-title":"Horm. Metab. Res."},{"key":"12794_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cen.13737","volume":"89","author":"ML Gild","year":"2018","unstructured":"Gild, M. L. et al. Role of DOTATATE-PET\/CT in preoperative assessment of Phaeochromocytoma and paragangliomas. Clin. Endocrinol. (Oxf). 89, 139\u2013147 (2018).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"12794_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/jpem-2020-0354","volume":"34","author":"SK Jaiswal","year":"2021","unstructured":"Jaiswal, S. K. et al. The utility of 68Ga-DOTATATE PET\/CT in localizing primary\/metastatic pheochromocytoma and paraganglioma in children and adolescents - a single-center experience. J. Pediatr. Endocrinol. Metab. 34, 109\u2013119 (2021).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"12794_CR25","doi-asserted-by":"crossref","unstructured":"Tan, T. H., Hussein, Z., Saad, F. F. A. & Shuaib, I. L. Diagnostic performance of (68)Ga-DOTATATE PET\/CT, (18)F-FDG PET\/CT and (131)I-MIBG scintigraphy in mapping metastatic pheochromocytoma and paraganglioma.\u00a0Nucl. Med. Mol. Imaging (2010). 49, 143\u2013151 (2015).","DOI":"10.1007\/s13139-015-0331-7"},{"key":"12794_CR26","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen, I. et al. Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin. Cancer Res. 21, 3888\u20133895 (2015).","journal-title":"Clin. Cancer Res."},{"key":"12794_CR27","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","volume":"43","author":"I Janssen","year":"2016","unstructured":"Janssen, I. et al. PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur. J. Nucl. Med. Mol. Imaging. 43, 1784\u20131791 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","volume":"45","author":"A Jha","year":"2018","unstructured":"Jha, A. et al. Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population. Eur. J. Nucl. Med. Mol. Imaging. 45, 787\u2013797 (2018).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR29","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1007\/s00330-024-10652-4","volume":"34","author":"A Jha","year":"2024","unstructured":"Jha, A. et al. Diagnostic performance of [68Ga]DOTATATE PET\/CT, [18F]FDG PET\/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma. Eur. Radiol. 34, 6488\u20136498 (2024).","journal-title":"Eur. Radiol."},{"key":"12794_CR30","doi-asserted-by":"crossref","unstructured":"Patel, M. et al. Performances of functional and anatomic imaging modalities in succinate dehydrogenase A-Related metastatic pheochromocytoma and paraganglioma. Cancers (Basel) 14, (2022).","DOI":"10.3390\/cancers14163886"},{"key":"12794_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2214\/AJR.21.26071","volume":"218","author":"A Jha","year":"2022","unstructured":"Jha, A. et al. Sporadic primary pheochromocytoma: A prospective intraindividual comparison of six imaging tests (CT, MRI, and PET\/CT using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA). AJR Am. J. Roentgenol. 218, 342\u2013350 (2022).","journal-title":"AJR Am. J. Roentgenol."},{"key":"12794_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","volume":"43","author":"A Archier","year":"2016","unstructured":"Archier, A. et al. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur. J. Nucl. Med. Mol. Imaging. 43, 1248\u20131257 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"12794_CR33","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2967\/jnumed.118.223016","volume":"60","author":"TA Hope","year":"2019","unstructured":"Hope, T. A., Calais, J., Zhang, L., Dieckmann, W. & Millo, C. 111In-pentetreotide scintigraphy versus 68Ga-DOTATATE PET: impact on Krenning scores and effect of tumor burden. J. Nucl. Med. 60, 1266\u20131269 (2019).","journal-title":"J. Nucl. Med."},{"key":"12794_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.humpath.2018.11.020","volume":"86","author":"H Leijon","year":"2019","unstructured":"Leijon, H. et al. Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas. Hum. Pathol. 86, 66\u201375 (2019).","journal-title":"Hum. Pathol."},{"key":"12794_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03595-1","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. Somatostatin receptor subtype 2A expression and genetics in 184 paragangliomas: a single center retrospective observational study. Endocrine https:\/\/doi.org\/10.1007\/s12020-023-03595-1 (2024).","journal-title":"Endocrine"},{"key":"12794_CR36","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.21037\/qims-21-652","volume":"12","author":"G Ma","year":"2022","unstructured":"Ma, G. et al. Quantitative analysis of 68Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography\/computed tomography imaging for the differential diagnosis of primary pheochromocytoma and paraganglioma. Quant. Imaging Med. Surg. 12, 2427\u20132440 (2022).","journal-title":"Quant. Imaging Med. Surg."},{"key":"12794_CR37","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1210\/clinem\/dgad166","volume":"108","author":"A Fischer","year":"2023","unstructured":"Fischer, A. et al. Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses. J. Clin. Endocrinol. Metab. 108, 2676\u20132685 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12794_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona, J., Ta\u00efeb, D. & Pacak, K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr. Rev. 38, 489\u2013515 (2017).","journal-title":"Endocr. Rev."},{"key":"12794_CR39","first-page":"685","volume":"86","author":"E van der Harst","year":"2001","unstructured":"van der Harst, E. et al. [123I]Metaiodobenzylguanidine and[111In]Octreotide uptake in benign and malignant Pheochromocytomas1. J. Clin. Endocrinol. Metabolism. 86, 685\u2013693 (2001).","journal-title":"J. Clin. Endocrinol. Metabolism"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12794-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:44:18Z","timestamp":1757310258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12794-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12794-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Boards (IRB) of Henan Provincial People\u2019s Hospital & Zhengzhou University People\u2019s Hospital (Approval No. 24-0510). This study is retrospective in nature, and the requirement for informed consent was waived by the IRB of Henan Provincial People\u2019s Hospital & Zhengzhou University People\u2019s Hospital in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}],"article-number":"27493"}}